• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与蒽环类药物心脏毒性相关的心脏病理学概述。

Overview of cardiac pathology in relation to anthracycline cardiotoxicity.

作者信息

Ferrans V J

出版信息

Cancer Treat Rep. 1978 Jun;62(6):955-61.

PMID:352510
Abstract

A review is presented of cardiac pathologic changes associated with acute and chronic toxicity of anthracyclines. These changes consist of cardiac dilatation, degeneration and atrophy of the muscle cells, and interstitial edema and fibrosis. The degeneration of cardiac muscle cells is a complex phenomenon that involves the myofibrils, the nucleus, the mitochondria and the membrane systems of the T-tubules, the sarcoplasmic reticulum, and the intercellular junctions. The pathogenesis of these alteration is discussed in terms of the biochemical effects of anthracyclines.

摘要

本文综述了与蒽环类药物急慢性毒性相关的心脏病理变化。这些变化包括心脏扩张、心肌细胞变性和萎缩,以及间质水肿和纤维化。心肌细胞变性是一种复杂的现象,涉及肌原纤维、细胞核、线粒体以及横管、肌浆网和细胞间连接的膜系统。从蒽环类药物的生化作用方面讨论了这些改变的发病机制。

相似文献

1
Overview of cardiac pathology in relation to anthracycline cardiotoxicity.与蒽环类药物心脏毒性相关的心脏病理学概述。
Cancer Treat Rep. 1978 Jun;62(6):955-61.
2
Clinical spectrum of anthracycline antibiotic cardiotoxicity.蒽环类抗生素心脏毒性的临床谱
Cancer Treat Rep. 1978 Jun;62(6):873-9.
3
Pathogenesis and prevention of doxorubicin cardiomyopathy.阿霉素心肌病的发病机制与预防
Tsitologiia. 1997;39(10):928-37.
4
Anthracycline cardiomyopathy monitored by morphologic changes.通过形态学变化监测蒽环类药物性心肌病。
Cancer Treat Rep. 1978 Jun;62(6):865-72.
5
An introduction to the metabolic determinants of anthracycline cardiotoxicity.蒽环类药物心脏毒性的代谢决定因素介绍
Cardiovasc Toxicol. 2007;7(2):80-5. doi: 10.1007/s12012-007-0011-7.
6
Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.阿霉素 - DNA复合物与柔红霉素的心脏毒性:通过心电图和心内膜活检进行评估
Cancer Treat Rep. 1978 Jun;62(6):935-9.
7
Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.使用心内膜心肌活检评估蒽环类药物所致心脏毒性。
Lancet Oncol. 2005 Feb;6(2):67. doi: 10.1016/S1470-2045(05)01719-5.
8
Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.阿霉素诱导的大鼠心脏毒性(心肌病和充血性心力衰竭)。
Cancer Res. 1977 Aug;37(8 Pt 1):2705-13.
9
[Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].[蒽环类药物的心脏毒性。关于12例儿科病例]
Pediatrie. 1981 Sep;36(6):437-50.
10
Role of mtDNA lesions in anthracycline cardiotoxicity.线粒体DNA损伤在蒽环类药物心脏毒性中的作用。
Cardiovasc Toxicol. 2007;7(2):108-13. doi: 10.1007/s12012-007-0009-1.

引用本文的文献

1
Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment.蒽环类药物所致心肌病:风险预测、预防及治疗
Nat Rev Cardiol. 2025 Jan 28. doi: 10.1038/s41569-025-01126-1.
2
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study.经典型霍奇金淋巴瘤患者的心血管疾病风险:一项基于丹麦全国登记的队列研究。
Eur J Haematol. 2025 Feb;114(2):343-352. doi: 10.1111/ejh.14334. Epub 2024 Nov 6.
3
An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity.
蒽环类药物所致心脏毒性潜在分子机制的最新进展
Front Pharmacol. 2024 Jun 26;15:1406247. doi: 10.3389/fphar.2024.1406247. eCollection 2024.
4
Challenging the status quo: a framework for mechanistic and human-relevant cardiovascular safety screening.挑战现状:一个用于机制性和与人类相关的心血管安全筛查的框架。
Front Toxicol. 2024 Mar 25;6:1352783. doi: 10.3389/ftox.2024.1352783. eCollection 2024.
5
The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity.先进心血管成像模式在心脏肿瘤学中的作用:从早期检测到阐明心脏毒性机制
J Clin Med. 2023 Jul 27;12(15):4945. doi: 10.3390/jcm12154945.
6
Biomimetic Nanozymes Suppressed Ferroptosis to Ameliorate Doxorubicin-Induced Cardiotoxicity via Synergetic Effect of Antioxidant Stress and GPX4 Restoration.仿生纳米酶通过抗氧化应激和 GPX4 恢复的协同作用抑制铁死亡,从而改善阿霉素诱导的心脏毒性。
Nutrients. 2023 Feb 22;15(5):1090. doi: 10.3390/nu15051090.
7
A Co(III) Complex of 1-Amino-4-hydroxy-9,10-anthraquinone Exhibits Apoptotic Action against MCF-7 Human Breast Cancer Cells.1-氨基-4-羟基-9,10-蒽醌的钴(III)配合物对MCF-7人乳腺癌细胞具有凋亡作用。
ACS Omega. 2021 Dec 29;7(1):1428-1436. doi: 10.1021/acsomega.1c06125. eCollection 2022 Jan 11.
8
Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.超高场心血管磁共振 T1 和 T2 mapping 用于评估大鼠模型中蒽环类药物诱导的心脏毒性:与组织病理学变化的对比验证。
J Cardiovasc Magn Reson. 2021 Jun 17;23(1):76. doi: 10.1186/s12968-021-00767-8.
9
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.设立心脏肿瘤学科室的基本原理:我们在梅奥诊所的经验。
Cardiooncology. 2016 Apr 19;2(1):5. doi: 10.1186/s40959-016-0014-2.
10
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer.乳腺癌治疗患者中心力衰竭的预防、检测和管理。
Curr Heart Fail Rep. 2020 Dec;17(6):397-408. doi: 10.1007/s11897-020-00486-8. Epub 2020 Sep 26.